U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
145951145951Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic CancerCompletedNo Results AvailableLocally Advanced or Metastatic Pancreatic CancerDrug: S-1https://ClinicalTrials.gov/show/NCT00651742
145952145952Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke SpasticityCompletedNo Results AvailableStroke|Muscle SpasticityBiological: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT00651729
145953145953T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantActive, not recruitingNo Results AvailableBreast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neuroblastoma|Ovarian Cancer|Testicular GOther: flow cytometry|Other: laboratory biomarker analysis|Other: Data Collectionhttps://ClinicalTrials.gov/show/NCT00651716
145954145954Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma PatientsCompletedNo Results AvailableMalignant MelanomaBiological: CYT004-MelQbG10 + Montanide|Biological: CYT004-MelQbG10 + Montanide + Imiquimod|Biological: CYT004-MelQbG10 + Imiquimod|Biological: CYT004-MelQbG10 intra nodal injectionhttps://ClinicalTrials.gov/show/NCT00651703
145955145955Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A TreatmentCompletedNo Results AvailableStroke|Muscle SpasticityBiological: Botulinum Toxin Type A|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00651690
145956145956Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal CancerRecruitingNo Results AvailableRectal CancerProcedure: HAL proctectomy|Procedure: "straight" laparoscopic proctectomy|Procedure: Hand-assisted laparoscopic proctectomy|Procedure: SL Proctectomyhttps://ClinicalTrials.gov/show/NCT00651677
145957145957A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Patients With Advanced MalignanciesCompletedNo Results AvailableAdvanced MalignanciesDrug: MLN8237https://ClinicalTrials.gov/show/NCT00651664
145958145958Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5CompletedNo Results AvailableAsthmaDrug: budesonide/formoterol|Drug: budesonide|Drug: formoterolhttps://ClinicalTrials.gov/show/NCT00651651
145959145959A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) GenotypeCompletedNo Results AvailableHealthyDrug: Treatment with ARQ 197https://ClinicalTrials.gov/show/NCT00651638
145960145960Reciprocating Medical Devices - a Study of a New Safety DeviceCompletedNo Results AvailableOsteoarthritis|Rheumatoid Arthritis|Trauma|Thyroid Nodule|CancerDevice: Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001|Device: conventional syringe - BD Ref 309604https://ClinicalTrials.gov/show/NCT00651625
145961145961Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution|Drug: Concurrent brimonidine 0.2% and 0.5% timololhttps://ClinicalTrials.gov/show/NCT00651612
145962145962Treatment of Vasomotor Symptoms in Korean Post Menopausal WomenCompletedNo Results AvailableVasomotor SymptomsDrug: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00651599
145963145963Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal UlcersCompletedNo Results AvailableAcute Bacterial Corneal Ulcers|Bacterial KeratitisDrug: Gatifloxacin 0.3% ophthalmic solution|Drug: Ciprofloxacin 0.3% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00651586
145964145964Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac SurgeryRecruitingNo Results AvailableFocus- Optimal HCT to Balance Anemia and RBC.Procedure: Blood transfusion at hematocrit value less than 25%|Procedure: Blood transfusion at hematocrit value less than 28%https://ClinicalTrials.gov/show/NCT00651573
145965145965Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)(COMPLETED)CompletedNo Results AvailableHyperlipidemiaDrug: ezetimibe (+) simvastatinhttps://ClinicalTrials.gov/show/NCT00651560
145966145966Symbicort in Asthmatic Children - SEEDLINGCompletedNo Results AvailableAsthmaDrug: budesonide/formoterol|Drug: budesonide|Drug: formoterolhttps://ClinicalTrials.gov/show/NCT00651547
145967145967To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal FemalesCompletedNo Results AvailableHealthy Volunteer|PostmenopausalDrug: Ronacalerethttps://ClinicalTrials.gov/show/NCT00651534
145968145968Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease PatientsRecruitingNo Results AvailableCoronary Artery Disease|Chronic Kidney Diseasehttps://ClinicalTrials.gov/show/NCT00651521
145969145969Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableNon-Small Cell Lung CancerDrug: KOS-1584https://ClinicalTrials.gov/show/NCT00651508
145970145970Activating Seniors to Improve Chronic Disease CareCompletedNo Results AvailableHealthyBehavioral: Patient decision aids for chronic conditionshttps://ClinicalTrials.gov/show/NCT00651495
145971145971Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)TerminatedHas ResultsKidney Neoplasms|Kidney (Renal Cell) CancerDrug: Everolimus|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00651482
145972145972Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.CompletedNo Results AvailableAcne VulgarisDrug: YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00651469
145973145973Mesothelioma Avastin Plus Pemetrexed-cisplatin StudyActive, not recruitingNo Results AvailableMesotheliomaDrug: Standard Chemotherapy (Pemetrexed and Cisplatin)|Drug: Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumabhttps://ClinicalTrials.gov/show/NCT00651456
145974145974Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's LymphomaTerminatedNo Results AvailableLymphoma, Non-Hodgkin'sDrug: Galiximabhttps://ClinicalTrials.gov/show/NCT00651443
145975145975Physical Functioning Following Total Hip ArthroplastyCompletedNo Results AvailableOsteoarthrosis, Balance Control, Voluntary Movement Controlhttps://ClinicalTrials.gov/show/NCT00651430
145976145976Use of Organic Germanium or Placebo for the Prevention of Radiation Induced FatigueRecruitingNo Results AvailableLocalized Breast Cancer|Localized Prostate Cancer|Patients Receiving External Beam RadiotherapyDietary Supplement: Organic Germanium|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00651417
145977145977Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)CompletedNo Results AvailableHypercholesterolemia|AtherosclerosisDrug: Ezetimibe|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00651404
145978145978Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)TerminatedNo Results AvailableHypercholesterolemia|AtherosclerosisDrug: Ezetimibe + Simvastatin|Drug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00651391
145979145979Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)TerminatedNo Results AvailableHypercholesterolemia|Atherosclerosis|Coronary Artery DiseaseDrug: Rosuvastatin|Drug: Ezetimibe + Atorvastatin|Drug: Double Atorvastatinhttps://ClinicalTrials.gov/show/NCT00651378
145980145980A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.TerminatedNo Results AvailableNeoplasmsDrug: JNJ-38877605https://ClinicalTrials.gov/show/NCT00651365

* Görseller ve İçerik tekif hakkına sahip olabilir